0001752724-21-001814.txt : 20210113 0001752724-21-001814.hdr.sgml : 20210113 20210113111045 ACCESSION NUMBER: 0001752724-21-001814 CONFORMED SUBMISSION TYPE: N-CEN PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20201031 FILED AS OF DATE: 20210113 DATE AS OF CHANGE: 20210113 EFFECTIVENESS DATE: 20210113 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Clough Funds Trust CENTRAL INDEX KEY: 0001638872 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FILING VALUES: FORM TYPE: N-CEN SEC ACT: 1940 Act SEC FILE NUMBER: 811-23059 FILM NUMBER: 21525432 BUSINESS ADDRESS: STREET 1: 1290 BROADWAY STREET 2: SUITE 1100 CITY: DENVER STATE: CO ZIP: 80203 BUSINESS PHONE: 303-623-2577 MAIL ADDRESS: STREET 1: 1290 BROADWAY STREET 2: SUITE 1100 CITY: DENVER STATE: CO ZIP: 80203 0001638872 S000050324 Clough Global Long/Short Fund C000158882 Investor Class CLOAX C000158883 Class C CLOCX C000158884 Class I CLOIX C000202463 Class A CLOVX N-CEN 1 primary_doc.xml X0303 N-CEN LIVE 0001638872 XXXXXXXX 811-23059 false false false N-1A true Clough Funds Trust 811-23059 0001638872 549300D7UXZPLKE4GC16 1290 Broadway, Suite 1000 Denver 80203 US-CO US 303-623-2577 ALPS Fund Services, Inc. 1290 Broadway, Suite 1000 Denver 80203 303.623.2577 regulatory documents and accounting records N N N-1A 1 Y Kevin McNally 002321552 Y Edmund J. Burke 001263210 Y Clifford J. Weber N/A N Jeremy W. Deems N/A N James M. Maxwell N/A N Lucas Foss N/A 1290 Broadway Suite 1000 Denver 80203 XXXXXX N N N N N N N N Ernst & Young LLP 42 N/A N N N N N N N Clough Global Long/Short Fund S000050324 5493003YXDFIDVKDM894 N 4 0 0 N/A N N N N N/A N/A N/A Rule 32a-4 (17 CFR 270.32a-4) Y Y Y N Clough Capital Partners L.P. 801-63142 000131257 549300EN8MICV62FEJ05 N ALPS Fund Services, Inc. 84-5730 N/A Y N N ICE Data Pricing & Reference Data, LLC 5493000NQ9LYLDBCTL34 N N STANDARD CHARTERED BANK (TAIWAN) LI N/A TW N Y Foreign custodian - rule 17f-5 (17 CFR 270.17f-5) CREDIT SUISSE (SCHWEIZ) AG N/A CH N Y Foreign custodian - rule 17f-5 (17 CFR 270.17f-5) State Street Bank and Trust N/A N N Bank - section 17(f)(1) (15 U.S.C. 80a-17(f)(1)) HONGKONG AND SHANGHAI BANKING CORPORATION N/A JP N Y Foreign custodian - rule 17f-5 (17 CFR 270.17f-5) CLEARSTREAM BANKING AG N/A DE N Y Foreign custodian - rule 17f-5 (17 CFR 270.17f-5) DEUTSCHE BANK AG, SEOUL BRANCH N/A KR N Y Foreign custodian - rule 17f-5 (17 CFR 270.17f-5) DEUTSCHE BANK AG N/A FR N Y Foreign custodian - rule 17f-5 (17 CFR 270.17f-5) HONGKONG AND SHANGHAI BANKING CORPORATION N/A HK N Y Foreign custodian - rule 17f-5 (17 CFR 270.17f-5) DEUTSCHE BANK AG N/A IN N Y Foreign custodian - rule 17f-5 (17 CFR 270.17f-5) N ALPS Fund Services, Inc. 84-5730 N/A Y N N ALPS Fund Services, Inc. 84-5730 N/A Y N N CITICORP SECURITIES SERVICES, INC. 008-32117 000015387 549300N0SOX9OZVKG341 8949 UBS SECURITIES LLC 008-22651 000007654 T6FIZBDPKLYJKFCRVK44 20290 MERRILL LYNCH, PIERCE, FENNER & SMITH INCORPORATED 008-07221 000007691 8NAV47T0Y26Q87Y0QP81 29592 INSTINET, LLC 008-23669 000007897 549300MGMN3RKMU8FT57 6854 WELLS FARGO SECURITIES, LLC 008-65876 000126292 PBLD0EJDB5FWOLXP3B76 8402 JEFFERIES LLC 008-15074 000002347 58PU97L1C0WSRCWADL48 20856 CREDIT SUISSE SECURITIES (USA) LLC 008-00422 000000816 1V8Y6QCX6YMJ2OELII46 13309 MORGAN STANLEY 008-68191 000149777 IGJSJL3JD5P30I6NJZ34 36970 SVB LEERINK LLC 008-48535 000039011 549300AAH7U76CEUBI94 7644 VIRTU AMERICAS LLC 008-68193 000149823 549300RA02N3BNSWBV74 15701 210170 MORGAN STANLEY 008-68191 000149777 IGJSJL3JD5P30I6NJZ34 4293064 GOLDMAN SACHS & CO. LLC 008-00129 000000361 FOR8UP27PHTHYVLBNG30 841166 MERRILL LYNCH, PIERCE, FENNER & SMITH INCORPORATED 008-07221 000007691 8NAV47T0Y26Q87Y0QP81 519600 JEFFERIES LLC 008-15074 000002347 58PU97L1C0WSRCWADL48 213218 ROBERT W BAIRD (RWB) 008-00497 000008158 549300772UJAHRD6LO53 45198539 LEGG MASON INVESTOR SERVICES, LLC 008-53089 000109064 N/A 890454 WELLS FARGO SECURITIES, LLC 008-65876 000126292 PBLD0EJDB5FWOLXP3B76 239940 SUSQUEHANNA FINANCIAL GROUP, LLLP 008-44325 000035865 549300E8QX0ZMRDC2M81 2057406 PIPER SANDLER 008-15204 000000665 549300GRQCWQ3XGH0H10 3203010 RBC CAPITAL MARKETS, LLC 008-45411 000031194 549300LCO2FLSSVFFR64 621404 58451901 Y 51495344 N N N N false false true false false false INTERNAL CONTROL RPT 2 fp0060624_clough-g1aiii.htm INTERNAL CONTROL REPORT

Report of Independent Registered Public Accounting Firm

 

To the Board of Trustees and Shareholders of

Clough Funds Trust

 

In planning and performing our audit of the financial statements of the Clough Global Long/Short Fund (the “Fund”), comprising the Clough Funds Trust (the “Trust”), as of and for the year ended October 31, 2020, in accordance with the standards of the Public Company Accounting Oversight Board (United States), we considered the Trust’s internal control over financial reporting, including controls over safeguarding securities, as a basis for designing our auditing procedures for the purpose of expressing our opinion on the financial statements and to comply with the requirements of Form N-CEN, but not for the purpose of expressing an opinion on the effectiveness of the Trust’s internal control over financial reporting. Accordingly, we express no such opinion.

 

The management of the Trust is responsible for establishing and maintaining effective internal control over financial reporting. In fulfilling this responsibility, estimates and judgments by management are required to assess the expected benefits and related costs of controls. A fund’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with U.S. generally accepted accounting principles. A fund’s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the fund; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with U.S. generally accepted accounting principles, and that receipts and expenditures of the fund are being made only in accordance with authorizations of management and trustees of the fund; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of a fund’s assets that could have a material effect on the financial statements.

 

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

 

A deficiency in internal control over financial reporting exists when the design or operation of a control does not allow management or employees, in the normal course of performing their assigned functions, to prevent or detect misstatements on a timely basis. A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the Fund’s annual or interim financial statements will not be prevented or detected on a timely basis.

 

Our consideration of the Trust’s internal control over financial reporting was for the limited purpose described in the first paragraph and would not necessarily disclose all deficiencies in internal control that might be material weaknesses under standards established by the Public Company Accounting Oversight Board (United States). However, we noted no deficiencies in the Trust’s internal control over financial reporting and its operation, including controls over safeguarding securities that we consider to be a material weakness as defined above as of October 31, 2020.

 

 

 

This report is intended solely for the information and use of management and the Board of Trustees of the Trust and the Securities and Exchange Commission and is not intended to be and should not be used by anyone other than these specified parties.

 

/s/ Ernst & Young LLP

 

Boston, Massachusetts

December 22, 2020